(MedPage Today) -- ORLANDO -- Estetrol (E4) -- one of four natural estrogens -- significantly reduced the weighted weekly score of moderate-to-severe vasomotor symptoms in postmenopausal women, according to an analysis of two phase III…
The U.S. Food and Drug Administration has approved elinzanetant, a new non-hormonal treatment to help women manage menopause symptoms such as hot flashes.
Nwafor Chinyere, popularly known as Lux by Etta, revealed how she was wrongly diagnosed with stage 3 cancer and subjected to months of chemotherapy that damaged parts of her system, leaving her with neuropathy (nerve pain and numbness in…
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday
The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after the drug was successfully tested at UVA Health and other sites in the United States and around the world.
By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug,…
(MedPage Today) -- The FDA approved elinzanetant (Lynkuet), a new type of nonhormonal drug to treat disruptive menopausal hot flashes, Bayer announced on Friday.
The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after the drug was successfully tested at UVA Health and other sites in the United States and around the world.